---
search:
  boost: 3
---

# Antidepressants

This is a subcategory of Central Nervous System (CNS) Agents.

## Decision Trees

- [CNS - Antidepressants - Auvelity](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBURTEyUkVIMDZCOU1EMUMwNDhCQUxaQzJXTiQlQCNjPTEkJUAjdD1n){ :target="_blank" rel="noopener" }
- [CNS - Antidepressants - Bupropion XL (generic of Forfivo XL), Duloxetine 40mg, Trazodone 300mg](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUMlg1UkFGRDRRUlJaUTcwRUo0QjdNRzFDUyQlQCNjPTEkJUAjdD1n){ :target="_blank" rel="noopener" }
- [CNS - Antidepressants - Fluoxetine 60mg, DR, Fluvoxamine ER]{ :target="_blank" rel"noopener" }
- [CNS - Antidepressants - Non-Preferred Products](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNUtCNUMzSlBGUkJTQTIyRE1aWUVaNEZUMiQlQCNjPTEkJUAjdD1n){ :target="_blank" rel="noopener" }
- [CNS - Antidepressants - Viibryd](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUQ0xEN1lTMzlPVkhJVzdEQTNIMzFON01NRSQlQCNjPTEkJUAjdD1n){ :target="_blank" rel="noopener" }

## Formulary

### Preferred

| Preferred                                             | Generic Name                                                  |         Quantity          |        Time (Days)        |
|:------------------------------------------------------|:--------------------------------------------------------------|:-------------------------:|:-------------------------:|
| Bupropion <sup>QL</sup>                               | Bupropion HCI Tab (all strengths)                             |            306            |            102            |
| Bupropion SR (generic of Wellbutrin SR) <sup>QL</sup> | Bupropion HCI SR Tab 12 HR (all strengths)                    |            204            |            102            |
| Bupropion XL (generic of Wellbutrin XL) <sup>QL</sup> | Bupropion HCI SR Tab 24 HR (all strengths)                    |            102            |            102            |
| Citalopram <sup>QL</sup>                              | Citalopram Hydrobromide (all strengths)                       | Determined pursuant to PA | Determined pursuant to PA |
| Citalopram <sup>QL</sup>                              | Citalopram Hydrobromide Tab (all strengths excl 40 MG)        |            153            |            102            |
| Citalopram <sup>QL</sup>                              | Citalopram Hydrobromide Tab 40 MG                             |            102            |            102            |
| Citalopram Soln <sup>QL</sup>                         | Citalopram Hydrobromide Oral Soln (all strengths)             |           2040            |            102            |
| Duloxetine 20, 30, 60 MG <sup>QL</sup>                | Duloxetine HCI Enteric Pellets Cap (all strengths excl 30 MG) |            204            |            102            |
| Duloxetine 20, 30, 60 MG <sup>QL</sup>                | Duloxetine HCI Enteric Pellets Cap 30 MG                      |            306            |            102            |
| Escitalopram <sup>QL</sup>                            | Escitalopram Oxalate Tab (all strengths excl 5 MG)            |            153            |            102            |
| Escitalopram <sup>QL</sup>                            | Escitalopram Oxalate Tab 5 MG                                 |            102            |            102            |
| Escitalopram Soln <sup>QL</sup>                       | Escitalopram Oxalate Soln 5 MG / 5 ML                         |           2040            |            102            |
| Fluoxetine 10, 20, 40 MG <sup>QL</sup>                | Fluoxetine HCI Cap (all strengths excl 40 MG)                 |            306            |            102            |
| Fluoxetine 10, 20, 40 MG <sup>QL</sup>                | Fluoxetine HCI Cap 40 MG                                      |            204            |            102            |
| Fluoxetine 10, 20, 40 MG <sup>QL</sup>                | Fluoxetine HCI Tab (all strengths excl 60 MG)                 |            306            |            102            |
| Fluoxetine Sol <sup>QL</sup>                          | Fluoxetine HCI Solution (all strengths)                       |           2040            |            102            |
| Fluvoxamine <sup>QL</sup>                             | Fluvoxamine Maleate Tab (all strengths)                       |            306            |            102            |
| Mirtazapine <sup>QL</sup>                             | Mirtazapine ODT / Tab (all strengths)                         |            102            |            102            |
| Nefazodone <sup>QL</sup>                              | Nefazodone HCI Tab (all strengths excl 200 MG)                |            204            |            102            |
| Nefazodone <sup>QL</sup>                              | Nefazodone HCI Tab 200 MG                                     |            306            |            102            |
| Paroxetine IR Tab, Sol <sup>QL</sup>                  | Paroxetine HCI Tab (all strengths excl 30 MG)                 |            102            |            102            |
| Paroxetine IR Tab, Sol <sup>QL</sup>                  | Paroxetine HCI Tab 30 MG                                      |            204            |            102            |
| Sertraline TABLETS                                    |                                                               |                           |                           |
| Tranylcypromine                                       |                                                               |                           |                           |
| Trazodone 50mg, 100mg, 150mg <sup>QL</sup>            | Trazodone HCI Tab (all strengths excl 300 MG)                 |            306            |            102            |
| Venlafaxine ER Cap <sup>QL</sup>                      | Venlafaxine HCI SR Cap 37.5 MG                                |            102            |            102            |
| Venlafaxine ER Cap <sup>QL</sup>                      | Venlafaxine HCI SR Cap 75 MG                                  |            306            |            102            |
| Venlafaxine ER Cap <sup>QL</sup>                      | Venlafaxine HCI SR Cap 150 MG                                 |            204            |            102            |
| Venlafaxine IR Tab <sup>QL</sup>                      | Venlafaxine HCI Tab (all strengths)                           |            306            |            102            |

### Non-Preferred

| Non-Preferred                                      | Generic Name                                                  |         Quantity          |        Time (Days)        |
|:---------------------------------------------------|:--------------------------------------------------------------|:-------------------------:|:-------------------------:|
| Aplenzin                                           |                                                               |                           |                           |
| Auvelity                                           |                                                               |                           |                           |
| Brisdelle                                          |                                                               |                           |                           |
| Bupropion XL (generic of Forfivo XL) <sup>QL</sup> | Bupropion HCI SR Tab 24 HR (all strengths)                    |            102            |            102            |
| Clomipramine                                       |                                                               |                           |                           |
| Desvenlafaxine                                     |                                                               |                           |                           |
| Drizalma Sprinkle                                  |                                                               |                           |                           |
| Duloxetine 40mg <sup>QL</sup>                      | Duloxetine HCI Enteric Pellets Cap (all strengths excl 30 MG) |            204            |            102            |
| Emsam                                              |                                                               |                           |                           |
| Fetzima                                            |                                                               |                           |                           |
| Fluoxetine 60mg <sup>QL</sup>                      | Fluoxetine HCI Tab 60 MG                                      | Determined pursuant to PA | Determined pursuant to PA |
| Fluoxetine DR <sup>QL</sup>                        |                                                               |                           |                           |
| Fluvoxamine ER <sup>QL</sup>                       |                                                               |                           |                           |
| Marplan                                            |                                                               |                           |                           |
| Paroxetine Cap                                     |                                                               |                           |                           |
| Paroxetine ER Tab                                  |                                                               |                           |                           |
| Pexeva                                             |                                                               |                           |                           |
| Phenelzine
| Sertraline CAPSULES                                |                                                               |Determined pursuant to PA  |Determined pursuant to PA
| Trazodone 300 MG <sup>QL</sup>                     | Trazodone HCI Tab 300 MG                                      |            102            |            102            |
| Trintellix                                         |                                                               |                           |                           |
| Venlafaxine ER Tab                                 |                                                               |                           |                           |
| Viibryd <sup>BvG ==(Process by NDC)==</sup>                             |                                                               |                           |                           |

## Authorizations

**Length of Authorizations**: 365 Days

### Grandfathering*

Patients who have a claim for a non-preferred drug in the previous 120 days will be automatically approved to continue the drug. Patients who have taken the drug previously but do not have claims history (e.g. new to Medicaid), will need to submit a prior authorization in order to continue coverage.

### Psychiatrist Exemption

Prescribers (as identified below) are exempt from prior authorization of any non-preferred antidepressant, or step therapy of any preferred drug,
in the standard tablet/capsule dosage forms. Other dosage forms may still require prior authorization. The exemption will be processed
by the claims system when the pharmacy has submitted the prescriber on the claim using the individual national provider identifier (NPI)
for the prescriber.

Prescribers are defined as: </br>
Physicians with a specialty in psychiatry, nurse practitioners certified in psychiatric mental health,
or clinical nurse specialists certified in psychiatric mental health, who are credentialed with the Ohio Department of Medicaid.

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least ^^30 days^^ with at least ^^two preferred^^ drugs
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)
 
### Dextromethorphan/Bupropion (Auvelity)

Additional Dextromethorphan/Bupropion (Auvelity) Criteria:

- Must have an inadequate clinical response of at least ^^30 days^^ with **ALL** of the following: 
   - ^^ONE^^ dopamine/norepinephrine reuptake inhibitor (DNRI)
   - ^^ONE^^ selective norepinephrine reuptake inhibitor (SNRI)
   - ^^TWO^^ selective serotonin reuptake inhibitors (SSRIs)(^^ONE^^ of which must be either vilazodone (Viibryd) OR vortioxetine (Trintellix))

 [**Vraylar for MDD Guidance](https://special-spoon-f542dccd.pages.github.io/Pharmacist%20Reference%20Guide/Medication%20Guidance/vraylar/?h=vray)

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

## Links

[Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)](https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7BCD777F63-7F18-4713-8D6A-B043BEE631F5%7D&file=Denial%20Language%20Updated%2009112023.docx&action=embedview&mobileredirect=true&wdStartOn=28&cid=f4472ece-6d4f-4694-b0c5-c150a2f53fea){:target="_blank" rel="noopener"} </br>
[Criteria](https://medicaid.ohio.gov/static/PHM/drug-coverage/20231001+UPDL+Criteria+_v2.FINAL.pdf#page=33){ :target="_blank" rel="noopener"} </br>
[Preferred Drug List](https://medicaid.ohio.gov/static/PHM/drug-coverage/20230701_UPDL_FINAL_ODM.approved.v2.pdf#page=15){ :target="_blank" rel="noopener"} </br>
[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf){ :target="_blank" rel="noopener"}
